Background: The value of prostate-specific antigen (PSA) for screening and management of prostate cancer (CaP) continues to engender much controversy in the medical and lay literature. This review is intended to critically analyze the literature to assess the utility of adding the calculation of PSA velocity (PSAV) in the screening and management of CaP.
Methods: A systematic review of electronic databases including Medline PaperChase, PubMed, and Scopus was conducted to identify English-language studies in the peer-reviewed literature from 1992 to 2013. The free text search was extended by adding the following keywords: prostate cancer, screening, surgery, radiation therapy, active surveillance, and PSAV. All matches from the searches were read, and the articles pertinent to an analysis of PSAV in clinical practice were included in this review.
Results: The design of much of the recent published literature on PSAV does not conform to the original description of PSAV or to the published guidelines regarding the number of PSA values and the interval of time over which the PSA values are obtained. This heterogeneity of definition is the source of much of the controversy regarding the clinical applications of PSAV. The preponderance of evidence suggests that there is high collinearity between PSA and PSAV and therefore the calculation of PSAV adds little to the measurement of PSA level.
Conclusions: PSAV calculation has been advocated by many investigators as a strategy to improve the screening and clinical management of patients with CaP. However, when PSAV definitions are rigorously applied, its calculation does not significantly enhance the clinical performance of PSA alone.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.urolonc.2014.04.010 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Nutritional Supplement with Fermented Soy in Patients Under Active Surveillance for Low-Risk or Intermediate-Risk Prostate Cancer: Results from the PRAEMUNE Trial.
Cancers (Basel)
October 2024
Department of Urology, University Hospitals Leuven, 3000 Leuven, Belgium.
To investigate the effect of a fermented soy supplement during 18 months in patients under active surveillance (AS) for low-risk and selected favorable intermediate-risk prostate cancer (PCa), with an emphasis on PSA modulation. Low-risk patients with ISUP grade 1, clinical stage cT1 or cT2a, PSA < 10 ng/mL and favorable intermediate-risk patients with ISUP grade 2 (<10% pattern 4), clinical stage T2b-c, PSA 10-20 ng/mL. The primary outcome was PSA response defined as maximum PSA rise less than or equal to 0.
View Article and Find Full Text PDFMidlife baseline prostate-specific antigen, velocity, and doubling time association with lethal prostate cancer and mortality.
Cancer
January 2025
VUI Center for Outcomes Research, Analysis, and Evaluation, Henry Ford Health System, Detroit, Michigan, USA.
Article Synopsis
- - The study investigates the effectiveness of midlife baseline prostate-specific antigen (MB PSA) compared to PSA doubling time (PSADT) and PSA velocity (PSAV) in predicting the risk of developing lethal prostate cancer in men aged 40-59.
- - A total of 77,594 men with at least two PSA tests and 11,634 men with three tests were analyzed, with data gathered from 1995 to 2019 to determine the occurrence of lethal prostate cancer diagnoses.
- - Results showed significant associations of both MB PSA and PSADT with lethal prostate cancer risk, indicating that those in the top 10th percentile for MB PSA had a 6.10 times higher hazard of developing lethal cancer while those
First Experimental Application of DNA-Layered Salmonid Alphavirus-Based Replicon Vaccine in Non-Salmonid Fish: Induced Early Semi-Specific Protection against Spring Viraemia of Carp Virus (SVCV) in Common Carp ().
Animals (Basel)
September 2024
HUN-REN Veterinary Medical Research Institute, H-1143 Budapest, Hungary.
Our study demonstrates the first application of the salmonid alphavirus-based replicon vector system (pSAV) as a DNA vaccine in a non-salmonid fish species, in common carp () against spring viraemia of carp virus (SVCV). SAV replicon encoding the glycoprotein of the SVCV was used as a DNA-layered plasmid, and its efficacy was compared with a previously described conventional DNA vaccine construct (pcDNA3.1 based vector) and with a control group (pcDNA3.
View Article and Find Full Text PDFsp. nov., a Novel Species of Entomopathogenic Fungi Associated with Weevils Impairing Coffee, Sugar Cane and Sweet Potato Cultivation.
J Fungi (Basel)
August 2024
Department of Biology, Technische Universität Darmstadt (TUDa), Schnittspahnstraße 10, 64287 Darmstadt, Germany.
Article Synopsis
- Research focuses on insect pathogenic fungi as eco-friendly alternatives to chemical insecticides, particularly in Cuba and Florida, where strains have been isolated from pests affecting coffee and sugar cane.* -
- A newly developed PCR method using ribosomal intergenic spacer (rIGS) sequences proves effective in distinguishing species within a complex, and it is enhanced with additional genetic markers.* -
- The findings characterize new fungal isolates associated with the coffee berry borer and propose these as a new taxon, demonstrating the utility of the rIGS-based PCR method for identifying new species in this context.*
Paraspecific neutralization capacity of polyvalent snake antivenom against Montivipera wagneri venom.
Toxicon
October 2024
Microbiology and Reference Laboratory and Biological, Products Department, General Directorate of Public Health, Turkish Ministery of Health, 06430, Ankara, Turkiye. Electronic address:
Purpose: This study aims to measure the paraspecific neutralization capacity of nationally produced HSGM polyvalent snake antivenom (HSGM-PSAV), produced using Macrovipera lebetina obtusa, Montivipera xanthina, and Vipera ammodytes montandoni venom, against the lethal effect of the venom of Montivipera wagneri, which is endemic to the Eastern Black Sea and Eastern Anatolia regions of Turkey.
Methods: The neutralization capacity of HSGM-PSAV against the lethal effect of M. wagneri venom was studied using the potency determination testing method specified in the Turkish and European Pharmacopoeia.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!